United States · FDA National Drug Code directory
Budesonide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-778_ef5a72fa-15a8-427d-83c5-74190a22ecd3
- Product NDC
- 65162-778
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Budesonide
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170915
- Source listing expiry
- 20261231
Source-listed ingredients
- BUDESONIDE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-10) · 65162-778-10
- 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-18) · 65162-778-18
- 300 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-30) · 65162-778-30
- 21 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65162-778-49) · 65162-778-49
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →